Par Drugs (India) Price History

PAR Stock   288.35  4.15  1.42%   
Below is the normalized historical share price chart for Par Drugs And extending back to May 30, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Par Drugs stands at 288.35, as last reported on the 27th of November, with the highest price reaching 294.85 and the lowest price hitting 285.30 during the day.
200 Day MA
242.7506
50 Day MA
260.6474
Beta
0.153
 
Covid
If you're considering investing in Par Stock, it is important to understand the factors that can impact its price. Par Drugs appears to be very steady, given 3 months investment horizon. Par Drugs And maintains Sharpe Ratio (i.e., Efficiency) of 0.0647, which implies the firm had a 0.0647% return per unit of risk over the last 3 months. We have found thirty technical indicators for Par Drugs And, which you can use to evaluate the volatility of the company. Please evaluate Par Drugs' Risk Adjusted Performance of 0.0796, semi deviation of 2.06, and Coefficient Of Variation of 1069.03 to confirm if our risk estimates are consistent with your expectations.
  
As of November 27, 2024, Total Stockholder Equity is expected to decline to about 483.9 M. In addition to that, Common Stock Shares Outstanding is expected to decline to about 11.2 M. Par Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0647

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsPAR
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 4.0
  actual daily
35
65% of assets are more volatile

Expected Return

 0.26
  actual daily
5
95% of assets have higher returns

Risk-Adjusted Return

 0.06
  actual daily
5
95% of assets perform better
Based on monthly moving average Par Drugs is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Par Drugs by adding it to a well-diversified portfolio.
Price Book
3.6668
Book Value
78.685
Enterprise Value
3.4 B
Enterprise Value Ebitda
11.9454
Price Sales
3.4024

Par Drugs Stock Price History Chart

There are several ways to analyze Par Stock price data. The simplest method is using a basic Par candlestick price chart, which shows Par Drugs price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceNovember 4, 2024305.5
Lowest PriceOctober 7, 2024221.1

Par Drugs November 27, 2024 Stock Price Synopsis

Various analyses of Par Drugs' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Par Stock. It can be used to describe the percentage change in the price of Par Drugs from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Par Stock.
Par Drugs Price Action Indicator(3.80)
Par Drugs Price Daily Balance Of Power(0.43)
Par Drugs Price Rate Of Daily Change 0.99 

Par Drugs November 27, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Par Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Par Drugs intraday prices and daily technical indicators to check the level of noise trading in Par Stock and then apply it to test your longer-term investment strategies against Par.

Par Stock Price History Data

The price series of Par Drugs for the period between Thu, Aug 29, 2024 and Wed, Nov 27, 2024 has a statistical range of 84.4 with a coefficient of variation of 10.1. The price distribution for the period has arithmetic mean of 256.43. The median price for the last 90 days is 244.69. The company completed stock split (2:1) on 27th of April 2021. Par Drugs And had dividends distributed to its stock-holders on 2021-11-22.
OpenHighLowCloseVolume
11/27/2024
 292.50  294.85  285.30  288.35 
11/26/2024 292.50  294.85  285.30  288.35  173,146 
11/25/2024 299.00  304.65  289.00  292.50  211,545 
11/22/2024 283.90  307.00  281.50  294.05  534,126 
11/21/2024 283.50  290.65  280.00  281.40  74,976 
11/20/2024 289.35  289.35  289.35  289.35  1.00 
11/19/2024 271.60  297.90  268.95  289.35  864,073 
11/18/2024 272.00  275.20  255.15  267.60  123,761 
11/14/2024 270.10  278.00  270.10  271.10  58,016 
11/13/2024 268.15  277.75  268.05  269.00  66,012 
11/12/2024 293.70  293.70  271.05  273.55  90,054 
11/11/2024 292.10  299.10  282.60  285.50  79,187 
11/08/2024 310.00  311.05  290.00  291.95  109,693 
11/07/2024 299.20  302.40  290.05  299.20  111,672 
11/06/2024 305.90  305.90  287.50  299.00  119,659 
11/05/2024 310.00  315.25  301.00  302.60  90,830 
11/04/2024 318.00  320.00  302.00  305.50  152,497 
11/01/2024 294.70  294.70  294.70  294.70  298,111 
10/31/2024 295.00  298.25  288.00  294.70  52,392 
10/30/2024 297.00  300.80  285.00  293.21  70,778 
10/29/2024 310.00  310.00  293.36  295.61  189,661 
10/28/2024 275.00  310.00  275.00  299.55  373,595 
10/25/2024 280.00  286.00  247.21  274.45  235,782 
10/24/2024 305.00  312.00  281.00  286.01  724,521 
10/23/2024 266.56  266.56  266.56  266.56  100,741 
10/22/2024 234.60  240.92  218.00  222.14  17,552 
10/21/2024 240.00  255.00  232.00  233.33  109,125 
10/18/2024 237.30  237.98  230.50  231.81  10,725 
10/17/2024 245.70  246.38  233.01  239.43  18,024 
10/16/2024 245.00  245.80  240.00  244.46  17,072 
10/15/2024 239.90  248.00  236.00  244.69  115,396 
10/14/2024 235.20  241.97  235.10  239.38  20,531 
10/11/2024 224.00  247.69  223.01  234.99  75,835 
10/10/2024 225.60  225.90  220.35  221.65  26,528 
10/09/2024 226.95  228.85  218.80  221.10  37,304 
10/08/2024 227.10  227.10  222.10  223.64  23,368 
10/07/2024 234.05  241.00  218.02  221.10  167,457 
10/04/2024 234.00  239.52  229.48  235.60  129,932 
10/03/2024 230.00  236.09  226.51  230.40  16,981 
10/01/2024 232.96  237.78  230.20  232.06  10,059 
09/30/2024 237.65  238.45  227.20  231.75  23,018 
09/27/2024 242.20  244.60  236.55  237.55  9,399 
09/26/2024 238.55  243.00  235.60  242.15  19,588 
09/25/2024 242.00  243.75  236.10  238.65  11,412 
09/24/2024 241.20  243.40  235.25  236.30  31,487 
09/23/2024 243.70  248.85  235.50  243.40  38,910 
09/20/2024 237.55  245.10  237.55  243.70  28,925 
09/19/2024 244.00  244.00  233.00  234.05  30,500 
09/18/2024 242.10  247.95  238.00  238.85  29,679 
09/17/2024 246.00  258.90  239.90  242.10  55,752 
09/16/2024 257.15  268.00  241.30  246.25  47,529 
09/13/2024 264.60  264.60  252.35  257.15  59,683 
09/12/2024 238.50  271.95  236.55  259.85  288,535 
09/11/2024 235.90  245.50  235.10  237.30  14,408 
09/10/2024 235.30  240.00  232.00  237.45  13,737 
09/09/2024 240.20  241.95  235.00  237.05  15,174 
09/06/2024 240.60  253.00  235.55  237.20  38,293 
09/05/2024 241.50  245.65  237.15  239.30  10,221 
09/04/2024 242.80  245.95  237.25  240.25  11,656 
09/03/2024 254.70  254.70  245.00  246.50  9,185 
09/02/2024 259.00  260.00  247.00  249.20  14,800 

About Par Drugs Stock history

Par Drugs investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Par is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Par Drugs And will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Par Drugs stock prices may prove useful in developing a viable investing in Par Drugs
Last ReportedProjected for Next Year
Common Stock Shares Outstanding14.2 M11.2 M
Net Income Applicable To Common Shares106 M65.2 M

Par Drugs Quarterly Net Working Capital

471.85 Million

Par Drugs Stock Technical Analysis

Par Drugs technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Par Drugs technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Par Drugs trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Sync Your Broker Now

   

Sync Your Broker

Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
All  Next Launch Module

Par Drugs Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Par Drugs' price direction in advance. Along with the technical and fundamental analysis of Par Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Par to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Par Stock analysis

When running Par Drugs' price analysis, check to measure Par Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Par Drugs is operating at the current time. Most of Par Drugs' value examination focuses on studying past and present price action to predict the probability of Par Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Par Drugs' price. Additionally, you may evaluate how the addition of Par Drugs to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments